Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Naphazoline manufacturers

16 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

16 products found

naphazoline + carboxymethylcellulose + chlorphenamine maleate

Ear/eye drops 0.1% W/V + 0.1% W/V + 0.01% W/V

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18273

Manufacturer usually replies in 1 days

naphazoline

Ear/eye/nose drops 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

naphazoline

Ear/eye/nose drops 0.4 % - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

naphazoline

Ear/eye/nose drops 0.1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20847

Manufacturer usually replies in 6 days

naphazoline + phenylephrine + menthol

Eye drops 0.05 % + 0.12 % + 0.005 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

Manufacturer usually replies in 9 days

naphazoline + chlorphenamine maleate

Ophthalmic solution 0.1 % + 0.01 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20122

Manufacturer usually replies in 7 days

naphazoline + phenylephrine hydrochloride + menthol

Ophthalmic solution 0.05 % + 0.12 % + 0.005 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20122

Manufacturer usually replies in 7 days

naphazoline + chlorphenamine + zinc sulphate

Eye drops 0.056 % + 0.01 % + 0.12 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20122

Manufacturer usually replies in 7 days

naphazoline + phenylephrine + chlorphenamine

Ophthalmic solution 0.5 % + 0.12 % + 0.1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20122

Manufacturer usually replies in 7 days

naphazoline + chlorphenamine maleate + carboxymethylcellulose

Eye drops 0.1 %w/v+0.01 % w/v+0.1 % w/v, 0.1 %w/v+0.01 % w/v+0.20 % w/v

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18647

Manufacturer usually replies in 8 days

naphazoline

Oral drops 0.10 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

Manufacturer usually replies in 11 days

naphazoline

Eye drops 0.0255 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

naphazoline + chlorphenamine maleate + zinc sulphate

Eye drops 0.056 %+0.01 %+0.012 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

naphazoline + phenylephrine

Eye drops 0.05 %+0.12 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19381

phenylephrine + naphazoline + menthol

Eye drops 0.12 %+0.5 %+0.005 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19731

boric acid + phenylephrine hydrochloride + naphazoline

Eye drops 1.0 %+0.12 %+0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

Naphazoline Manufacturer

Naphazoline is commonly known as a vasoconstrictor. To reduce eye redness, It operates by narrowing swollen blood vessels in your eyes. Naphazoline ophthalmic is mainly for the short release of minor eye redness or trouble caused by minor burdens. It is also used for purposes not recorded in this medication guide. You should not use it if you have narrow-angle glaucoma. Discontinue using naphazoline ophthalmic and call your doctor at once if you are having worse eye redness, eye discomfort, vision fluctuations, critical dizziness, or headache, buzzing in ears, or feeling short of inhalation.

How does Naphazoline work?

Naphazoline is mainly used to temporarily relieve your eye redness, watering, itching, and puffiness that usually occur with allergies. It is a decongestant, which belongs to a class of cure mainly associated with sympathomimetic amines.

How much money does Naphazoline cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the cost. In the US, The cost of naphazoline ophthalmic solution 0.1% is around $14 for a supply of 15 milliliters, depending on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Naphazoline offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Naphazoline manufacturers and Naphazoline suppliers that you are looking for. These also enable you to check the dossier status of Naphazoline, and the GMP approvals of the different variants of Naphazoline. Also, each manufacturer or supplier product description contains essential information about Naphazoline including clinical data, stability zones, countries where Naphazoline is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are on boarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.